Search

everythinglearnresearchcommunity

for

Search:↓

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

Skin issues can indicate immune system problems.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

IL-1 alpha stops hair follicle growth and hair production.

QLT0267 stops hair follicle cell growth and movement.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Ishige sinicola extract may help prevent muscle atrophy through its antioxidant and anti-inflammatory effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Certain proteins are significantly increased in the skin of people with hidradenitis suppurativa.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Ritlecitinib is safe and may effectively treat alopecia areata.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.